MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202527007667 A) filed by Kashiv Biosciences, Llc, Piscataway, U.S.A., on Jan. 30, for 'a stable liquid composition of ocrelizumab.'
Inventor(s) include Avadhani, Kiran Suresh; Joshi, Kaushal; and Rawal, Chandramauli.
The application for the patent was published on March 7, under issue no. 10/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a stable liquid composition comprising Ocrelizumab antibody. More specifically, the present invention further provides stable liquid composition does not comprise a hyaluronidase enzyme."
The patent application was internationally filed on July 27, 202...